semaglutide armonk ny Effect of therapy on CRP rate stratified by groups of Retrospective comparison of the clinical

The funder was not involved in the data collection, analysis or data interpretation

Which substances and methods are prohibited

GLP-1 RAs are increasingly prescribed to reproductive-aged female patients for type 2 diabetes and obesity, yet menstrual dysregulation was not systematically captured or reported as an adverse effect in the pivotal clinical trials for these agents, leaving a critical gap in our understanding of their gynecologic safety profile, stated researchers Connor Frey, MD, and Mahyar Etminan, PharmD, MSc, from the University of British Columbia

Apovian has seen patients who lose weight on GLP-1 drugs develop osteopenia, or low bone mass